论文部分内容阅读
默克公司的抗血小板凝集药Ａｇｇｒａｓｔａｔ（Ｔｉｒｏｆｉｂａｎ盐酸盐）为糖蛋白Ⅱｂ／Ⅲａ（ＧＰⅡｂ／Ⅲａ）抑制剂。体外实验表明，该药能抑制各种促凝剂诱导的人体凝胶过滤后的血小板凝集，对ＡＤＰ（１０μｍｏｌ／Ｌ）、胶原蛋白（１０μｇ／ｍｌ）、Ｕ４６６１...
Merck anti-platelet aggregation drug Aggrastat (Tirofiban hydrochloride) glycoprotein Ⅱ b / Ⅲ a (GP Ⅱ b / Ⅲ a) inhibitors. In vitro experiments show that the drug can inhibit a variety of coagulant-induced human gel filtration platelet aggregation, ADP (10μmol / L), collagen (10μg / ml), U4661 ...